Germolec DR - Search Results

1

Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Corsini E, Luebke RW, Germolec DR, DeWitt JC. Corsini E, et al. Among authors: germolec dr. Toxicol Lett. 2014 Oct 15;230(2):263-70. doi: 10.1016/j.toxlet.2014.01.038. Epub 2014 Feb 3. Toxicol Lett. 2014. PMID: 24503008 Free PMC article. Review.

2

Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology.

Luster MI, Pait DG, Portier C, Rosenthal GJ, Germolec DR, Comment CE, Munson AE, White K, Pollock P. Luster MI, et al. Among authors: germolec dr. Toxicol Lett. 1992 Dec;64-65 Spec No:71-8. doi: 10.1016/0378-4274(92)90174-i. Toxicol Lett. 1992. PMID: 1471226 Review.

3

Use of animal studies in risk assessment for immunotoxicology.

Luster MI, Portier C, Pait DG, Germolec DR. Luster MI, et al. Among authors: germolec dr. Toxicology. 1994 Sep 6;92(1-3):229-43. doi: 10.1016/0300-483x(94)90180-5. Toxicology. 1994. PMID: 7940563 Review.

4

Asbestos stimulates IL-8 production from human lung epithelial cells.

Rosenthal GJ, Germolec DR, Blazka ME, Corsini E, Simeonova P, Pollock P, Kong LY, Kwon J, Luster MI. Rosenthal GJ, et al. Among authors: germolec dr. J Immunol. 1994 Oct 1;153(7):3237-44. J Immunol. 1994. PMID: 8089496

5

Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests.

Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W, et al. Luster MI, et al. Among authors: germolec dr. Fundam Appl Toxicol. 1993 Jul;21(1):71-82. doi: 10.1006/faat.1993.1074. Fundam Appl Toxicol. 1993. PMID: 8365588

6

Role of keratinocyte-derived cytokines in chemical toxicity.

Luster MI, Wilmer JL, Germolec DR, Spalding J, Yoshida T, Gaido K, Simeonova PP, Burleson FG, Bruccoleri A. Luster MI, et al. Among authors: germolec dr. Toxicol Lett. 1995 Dec;82-83:471-6. doi: 10.1016/0378-4274(95)03577-x. Toxicol Lett. 1995. PMID: 8597097

7

Immunotoxicity of sodium bromate in female B6C3F1 mice: a 28-day drinking water study.

Guo TL, McCay JA, Karrow NA, Brown RD, Musgrove DL, Luebke RW, Germolec DR, White KL Jr. Guo TL, et al. Among authors: germolec dr. Drug Chem Toxicol. 2001 May;24(2):129-49. doi: 10.1081/dct-100102606. Drug Chem Toxicol. 2001. PMID: 11360431

8

Evaluation of the immunomodulatory effects of the disinfection by-product, sodium chlorite, in female B6C3F1 mice: a drinking water study.

Karrow NA, Guo TL, McCay JA, Johnson GW, Brown RD, Musgrove DL, Germolec DR, Luebke RW, White KL Jr. Karrow NA, et al. Among authors: germolec dr. Drug Chem Toxicol. 2001 Aug;24(3):239-58. doi: 10.1081/dct-100103722. Drug Chem Toxicol. 2001. PMID: 11452397

9

Extended histopathology in immunotoxicity testing: interlaboratory validation studies.

Germolec DR, Nyska A, Kashon M, Kuper CF, Portier C, Kommineni C, Johnson KA, Luster MI. Germolec DR, et al. Toxicol Sci. 2004 Mar;78(1):107-15. doi: 10.1093/toxsci/kfh049. Epub 2003 Dec 22. Toxicol Sci. 2004. PMID: 14691208

10

Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistance.

Germolec DR. Germolec DR. Toxicol Lett. 2004 Apr 1;149(1-3):109-14. doi: 10.1016/j.toxlet.2003.12.025. Toxicol Lett. 2004. PMID: 15093255 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page